Cargando…

Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier

The blood–brain barrier (BBB) is a highly specialized neurovascular unit, initially described as an intact barrier to prevent toxins, pathogens, and potentially harmful substances from entering the brain. An intact BBB is also critical for the maintenance of normal neuronal function. In cerebral vas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jia, Zheng, Meng, Shimoni, Olga, Banks, William A., Bush, Ashley I., Gamble, Jennifer R., Shi, Bingyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373165/ https://www.ncbi.nlm.nih.gov/pubmed/34085418 http://dx.doi.org/10.1002/advs.202101090

Ejemplares similares

Blood-brain barrier–penetrating siRNA nanomedicine for Alzheimer’s disease therapy
por: Zhou, Yutong, et al.
Publicado: (2020)

Blood-brain barrier–penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy
por: Zou, Yan, et al.
Publicado: (2022)

Characteristics of compounds that cross the blood-brain barrier
por: Banks, William A
Publicado: (2009)

A Unique Carrier for Delivery of Therapeutic Compounds beyond the Blood-Brain Barrier
por: Karkan, Delara, et al.
Publicado: (2008)

Role of the blood–brain barrier in the evolution of feeding and cognition
por: Banks, William A
Publicado: (2012)

Endocytosis of insulin at the blood-brain barrier
por: Pemberton, Sarah, et al.
Publicado: (2022)

Correction: A Unique Carrier for Delivery of Therapeutic Compounds beyond the Blood-Brain Barrier
por: Karkan, Delara, et al.
Publicado: (2008)

Correction: A Unique Carrier for Delivery of Therapeutic Compounds beyond the Blood-Brain Barrier
por: Karkan, Delara, et al.
Publicado: (2008)

Correction: A Unique Carrier for Delivery of Therapeutic Compounds beyond the Blood-Brain Barrier
por: Karkan, Delara, et al.
Publicado: (2008)

The Blood–Brain Barrier, Oxidative Stress, and Insulin Resistance
por: Banks, William A., et al.
Publicado: (2021)

SARS-CoV-2, the blood-brain barrier, and neuroinflammation
por: Banks, William A
Publicado: (2023)

Profiling Solute Carrier Transporters in the Human Blood-Brain Barrier
por: Geier, Ethan G., et al.
Publicado: (2013)

Neurological disorders and therapeutics targeted to surmount the blood–brain barrier
por: Kanwar, Jagat R, et al.
Publicado: (2012)

Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain
por: Pardridge, William M.
Publicado: (2020)

The Effects of Viruses on Insulin Sensitivity and Blood–Brain Barrier Function
por: Raber, Jacob, et al.
Publicado: (2023)

Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease
por: Banks, William A
Publicado: (2008)

The impact of acute rosiglitazone on insulin pharmacokinetics at the blood‐brain barrier
por: Galindo, Demi C., et al.
Publicado: (2020)

Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance
por: Rhea, Elizabeth M., et al.
Publicado: (2019)

Age-Associated Changes in the Immune System and Blood–Brain Barrier Functions
por: Erickson, Michelle A., et al.
Publicado: (2019)

Imperatorin is Transported through Blood-Brain Barrier by Carrier-Mediated Transporters
por: Tun, Temdara, et al.
Publicado: (2017)

Blood–Brain Barrier Solute Carrier Transporters and Motor Neuron Disease
por: Latif, Sana, et al.
Publicado: (2022)

Interactions of SARS-CoV-2 with the Blood–Brain Barrier
por: Erickson, Michelle A., et al.
Publicado: (2021)

Effects of Rapamycin on Insulin Brain Endothelial Cell Binding and Blood–Brain Barrier Transport
por: Nguyen, Steven, et al.
Publicado: (2021)

In vitro modeling of blood–brain barrier and interface functions in neuroimmune communication
por: Erickson, Michelle A., et al.
Publicado: (2020)

Neuroimmune Axes of the Blood–Brain Barriers and Blood–Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions
por: Erickson, Michelle A., et al.
Publicado: (2018)

Pitavastatin Ameliorates Lipopolysaccharide-Induced Blood-Brain Barrier Dysfunction
por: Fujimoto, Takashi, et al.
Publicado: (2021)

Occludin regulation of blood–brain barrier and potential therapeutic target in ischemic stroke
por: Yuan, Shuhua, et al.
Publicado: (2020)

Blood-Brain Barrier Dysfunction in CNS Disorders and Putative Therapeutic Targets: An Overview
por: Archie, Sabrina Rahman, et al.
Publicado: (2021)

Blood–brain barrier: a real obstacle for therapeutics
por: Shiekh, Farooq A
Publicado: (2012)

Barrier mechanisms in the Drosophila blood-brain barrier
por: Hindle, Samantha J., et al.
Publicado: (2014)

Ultrastructural Remodeling of the Blood–Brain Barrier and Neurovascular Unit by Lipopolysaccharide-Induced Neuroinflammation
por: Erickson, Michelle A., et al.
Publicado: (2023)

Targeting microRNAs to Regulate the Integrity of the Blood–Brain Barrier
por: Wang, Juntao, et al.
Publicado: (2021)

Alpha Adrenergic Induction of Transport of Lysosomal Enzyme across the Blood-Brain Barrier
por: Urayama, Akihiko, et al.
Publicado: (2015)

Borneol and Tetrandrine Modulate the Blood–Brain Barrier and Blood–Tumor Barrier to Improve the Therapeutic Efficacy of 5-Fluorouracil in Brain Metastasis
por: Lin, Jui-Feng, et al.
Publicado: (2022)

Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation
por: Banks, William A., et al.
Publicado: (2020)

Optimizing superparamagnetic iron oxide nanoparticles as drug carriers using an in vitro blood–brain barrier model
por: Shi, Di, et al.
Publicado: (2016)

Underlying Mechanisms and Potential Therapeutic Molecular Targets in Blood-Brain Barrier Disruption after Subarachnoid Hemorrhage
por: Li, Yuchen, et al.
Publicado: (2020)

Potential therapeutic molecular targets for blood-brain barrier disruption after subarachnoid hemorrhage
por: Kanamaru, Hideki, et al.
Publicado: (2019)

Sortilins in the blood-brain barrier: impact on barrier integrity
por: Toth, Andrea E., et al.
Publicado: (2022)

Engineering antibody and protein therapeutics to cross the blood–brain barrier
por: Zhao, Peng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fc9fku326ujrtmheaas01vvr7m